The protein/peptide system can grow on demand by simply displacing the interface.
CREDIT
QMUL
Researchers at Queen Mary University of London (QMUL) have developed a way of assembling organic molecules into complex tubular tissue-like structures without the use of moulds or techniques like 3D printing.
The study, which will appear on Monday 28 September in the journal Nature Chemistry, describes how peptides and proteins can be used to create materials that exhibit dynamic behaviors found in biological tissues like growth, morphogenesis, and healing.
The method uses solutions of peptide and protein molecules that, upon touching each other, self-assemble to form a dynamic tissue at the point at which they meet. As the material assembles itself it can be easily guided to grow into complex shapes.
This discovery could lead to the engineering of tissues like veins, arteries, or even the blood-brain barrier, which would allow scientists to study diseases such as Alzheimer’s with a high level of similarity to the real tissue, which is currently impossible. The technique could also contribute to the creation of better implants, complex tissues, or more effective drug screening methods.
Alvaro Mata, Director of the Institute of Bioengineering at QMUL and lead author of the paper, said: “What is most exciting about this discovery is the possibility for us to use peptides and proteins as building-blocks of materials with the capacity to controllably grow or change shape, solely by self-assembly.
Read more: Self-assembling material that grows and changes shape could lead to artificial arteries
The Latest on: Protein/peptide system
via Google News
The Latest on: Protein/peptide system
- Coordinated Offensive on Alzheimer’s Diseaseon January 13, 2022 at 8:48 am
Alzheimer’s Disease (AD) is a feared diagnosis that afflicts many older individuals, particularly women and those with a genetic predisposition for the condition. AD is so frightening in large part ...
- Restrictions in Protein and Peptide Learningon January 13, 2022 at 6:48 am
Section I (System Biology – in silico Characterization of Proteins and Peptides) begins with Chapter ... toolbox and its use in determining protein stability and analysis to improve ...
- Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditison January 12, 2022 at 10:18 pm
Therefore, the team investigated whether any peptide sequences in the spike protein could lead to a cross-reactive immune ... is due to cross-reactive reactions of the adaptive immune system. The team ...
- Vaxxinity Announces First Parkinson’s Disease Patient Dosed in Part B of Phase 1 Clinical Trial of UB-312on January 12, 2022 at 6:22 am
(Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that the first patient with Parkinson’s disease (PD) has been dosed with UB-312 ...
- Reviewing the Top 22 Best Collagen Supplements to Buy in 2022on January 12, 2022 at 1:30 am
More people use protein supplements today than ever. Protein collagen supplements deliver anti-aging effects, improve skin health, and support joint health.
- How a potent antifibrotic peptide works and why it could reverse scarring in multiple organson January 10, 2022 at 1:01 pm
The E4 peptide is derived from a fragment of a collagen protein. However ... that E4 had the same functions in a dish and in a living system, activating the urokinase pathway in both cases.
- SARS-CoV-2 Protein Orf6 Suppresses MHC-I And Recognition By Cytotoxic T Cellson January 6, 2022 at 4:00 pm
MHC-I presents peptides derived from endogenous ... to some aspects of the immune system. This study shows that SARS-CoV-2 targets a key regulatory protein at two different levels.
- System-Wide Investigation of ErbB4 Reveals 19 Sites of Tyr Phosphorylation that Are Unusually Selective in their Recruitment Propertieson January 4, 2022 at 4:00 pm
The first three members of the ErbB family of receptor tyrosine kinases activate a wide variety of signaling pathways and are frequently misregulated in cancer. Much less is known about ErbB4. Here, ...
via Bing News
